Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 493.00
Ask: 494.00
Change: 0.50 (0.10%)
Spread: 1.00 (0.203%)
Open: 494.00
High: 494.00
Low: 492.00
Prev. Close: 493.50
HGT Live PriceLast checked at -
HgCapital is an Investment Trust

To provide shareholders with long-term capital appreciation in excess of the FTSE All Share Index by investing in unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HgCapital Trust - 2023 Preliminary Trading Update

5 Feb 2024 07:00

RNS Number : 9431B
HgCapital Trust PLC
05 February 2024
 

HgCapital Trust plc

PRELIMINARY TRADING UPDATE FOR THE YEAR ENDED 31 DECEMBER 2023

 

RESILIENT ESTIMATED NAV PERFORMANCE IN A CHALLENGING MACRO ENVIRONMENT DRIVEN BY STRONG TRADING IN THE UNDERLYING PORTFOLIO

 

London, 5 February 2024: HgCapital Trust plc ('HgT') today announces a preliminary trading update for the 12 months ended 31 December 2023.

 

HgT provides investors with a listed vehicle to invest in unquoted businesses managed by Hg, Europe's largest investor in software & services companies.

The objective of HgT is to provide shareholders with consistent long?term returns in excess of the FTSE All?Share Index by investing predominantly in unquoted businesses where value can be created through strategic and operational change.

Highlights for 2023 include:

· Estimated Net Asset Value ('NAV') per share of 498.6 pence (unaudited)

· Total estimated NAV return per share, on a total return basis, of 10.7%1

· Total share price return of 26.2%1

· Discount narrowed from 23% to 13%

· Top 20 (77% of the portfolio) LTM revenue and EBITDA growth of 25% and 28% respectively for the year ended 31 December 2023

· Investments of £71 million and realisations of £343 million

· Year-end available liquid resources of £625 million (including a £350 million undrawn credit facility)

· Year-end outstanding commitments to Hg funds of £1.0 billion

NAV growth

HgT's unaudited estimated NAV as at 31 December 2023 was £2.3 billion, which represents an estimated NAV per share of 498.6 pence, based on portfolio company valuations at 31 December and reviewed by the HgT AVRC. This growth was predominantly driven by strong trading performance in the underlying portfolio.

Investments and realisations

· HgT's share of deployment from new and follow-on investments made during 2023 was £71 million, including GTreasury, Nomadia, JTL, P&I and Howden

 

· HgT's share of proceeds from exits and refinancings during the period was £343 million, including secondary sales from Hg Genesis 8 and Hg Saturn 3, as well as the full exits of Transporeon and Commify. Full and partial exits represented an average uplift of 25% to their carrying values at 31 December 2022

 

Post- period balance sheet adjustments

Allowing for all transactions announced and not completed at the end of 2023:

· Available liquid resources of £735 million (including a £350 million undrawn credit facility)

· Outstanding commitments of £808 million

 

 

Hg REALISATION ACTIVITY CONTINUES TO HIGHLIGHT THE FUNDAMENTAL STRENGTH OF THE UNDERLYING PORTFOLIO

The sale of Argus announced in January 2024 represented the fourth material realisation event announced by Hg over the prior four weeks, resulting in c. $3.5 billion of proceeds that will be returned to Hg clients, including c. £295 million to HgT, once these transactions close in 2024.

This realisation represents Hg's 13th liquidity event since the start of 2023 and the 29th liquidity event completed over the last two years, the equivalent of more than one per month and representing proceeds from nearly half of the Hg portfolio over this period. 

This realisation activity sets Hg apart in a year when many other private equity firms struggled to generate liquidity from their portfolios. Hg believes its realisation activity in 2023 was a clear differentiator for HgT, highlighting the fundamental strengths and attractiveness of the underlying portfolio to both trade and financial buyers.

HgT will report its full year audited results for 2023 on 11 March 2024.

 

- ends -

 

For further information please contact:

 

For further details:

 

HgCapital Trust plc

Laura Dixon (Senior Investor Relations Manager, Hg) +44 (0) 78 2459 2894

 

Brunswick

Sofie Brewis +44 (0)20 7404 5959

 

Notes:

1. Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

2. This announcement may include "forward-looking statements". These forward-looking statements are statements regarding the Company's objectives, intentions, beliefs or current expectations with respect to, amongst other things, the Company's financial position, business strategy, results of operations, liquidity, prospects and growth. Forward-looking statements are subject to risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Accordingly, the Company's actual future financial results, operational performance and achievements may differ materially from those expressed in, or implied by, the statements. Given these uncertainties, prospective investors are cautioned not to place any undue reliance on such forward-looking statements, which speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the Company's expectations with regard to them or any change in events, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Regulation Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

3. Past performance is not a reliable indicator of future results. The value of shares and the income from them can go down as well as up as a result of market and currency fluctuations. You may not get back the amount you invest.

 

 

 About HgCapital Trust plc

HgCapital Trust plc is an investment company whose shares are listed on the London Stock Exchange (HGT.L). HgT gives investors exposure, through a liquid vehicle, to a portfolio of high-growth unquoted companies, managed by Hg, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors.

Further information on HgT including a short introduction video is available here: https://www.hgcapitaltrust.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUWGPUPCGRC
Date   Source Headline
22nd Oct 20195:43 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHg invests in Argus Media
9th Sep 20197:00 amRNSInterim Report and Accounts
9th Sep 20197:00 amRNSHalf-year Report
5th Sep 20197:00 amRNSRegister Group joins team.blue
2nd Jul 201911:51 amRNSHolding(s) in Company
1st Jul 20197:00 amRNSTotal Voting Rights
26th Jun 20197:00 amRNSBlock Listing Application
18th Jun 201912:35 pmRNSHolding(s) in Company
17th Jun 20194:22 pmRNSHolding(s) in Company
14th Jun 20193:27 pmRNSDirector/PDMR Shareholding
14th Jun 20197:00 amRNSResult of Placing
10th Jun 20197:00 amRNSPlacing to raise up to approximately £80 million
7th Jun 20197:00 amRNSPerformance at Month End
28th May 20197:00 amRNSTotal Voting Rights after sub-division of shares
23rd May 20197:58 amRNSSub-Division of Shares
20th May 20195:07 pmRNSDirector/PDMR Shareholding - Replacement
17th May 20195:15 pmRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSPerformance at Month End
7th May 20197:00 amRNSHg invests in Litera Microsystems
3rd May 20193:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20194:35 pmRNSResult of AGM
18th Apr 20197:00 amRNSHg purchases Cinven stake in Visma
9th Apr 20197:00 amRNSPerformance at Month End
22nd Mar 20194:55 pmRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSHg agrees the sale of Foundry
11th Mar 20197:00 amRNSAnnual Financial Report
11th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
29th Jan 20197:31 amRNSHg completes refinancing of A-Plan
29th Jan 20197:30 amRNSHg invests in Transporeon Group
22nd Jan 20192:14 pmRNSHolding(s) in Company
22nd Jan 20199:40 amRNSVisma welcomes CPPIB as new investor
21st Dec 20182:00 pmRNSHg invests in Combell Group
19th Dec 20185:01 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSPerformance at Month End
9th Nov 20189:28 amRNSHg agrees the sale of Atlas to Mintra Group
9th Nov 20187:00 amRNSPerformance at Month End
5th Nov 20185:11 pmRNSDirector/PDMR Shareholding
30th Oct 201812:19 pmRNSDirector/PDMR Shareholding - Replacement
30th Oct 201811:36 amRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSPerformance at Month End
1st Oct 20188:30 amRNSSale of Lumesse
10th Sep 20184:04 pmRNSDirector/PDMR Shareholding
10th Sep 20187:10 amRNSHg announces an investment in BrightPay
10th Sep 20187:00 amRNSHalf-year Report
10th Sep 20187:00 amRNSInterim Results - Six Months Ended 30 June 2018
30th Aug 20187:00 amRNSHg investment into Allocate Software from Hg8 Fund
20th Aug 201811:26 amRNSSyneos Health Acquires Kinapse
15th Jun 20187:00 amRNSPerformance at Month End
14th Jun 20187:30 amRNSHg invests in IT Relation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.